• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

探索作为纳米级苯妥英递送中分离出的生物聚合物的生物阻滞剂兼稳定剂的内在新特性。

Exploration of Inbuilt Novel Properties as Bioretardant Cum Stabilizer of Isolated Biopolymer from in Delivery of Nanosized Phenytoin.

作者信息

Kumar Sushant, Madhav N V Satheesh

机构信息

Faculty of Pharmacy, Pharmacy College Saifai, Uttar Pradesh University of Medical Sciences, Saifai, Etawah, U.P., 26130, India.

Faculty of Pharmacy, DIT Univesity, Dehradun, U.K., India.

出版信息

Iran J Pharm Res. 2021 Summer;20(3):78-93. doi: 10.22037/ijpr.2021.113734.14457.

DOI:10.22037/ijpr.2021.113734.14457
PMID:34903971
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8653676/
Abstract

The research aims to develop bionanosuspension using a biopolymer isolated from fruit that constitutes potential and natural polymeric properties. At first, the biomaterial was isolated from the natural fruit pulp of by an economical method of isolation. The model drug was nanosized by a novel sonication method. The isolated biopolymer was characterized for its polymeric properties, and its potential capabilities were evaluated in the delivery of nanosized phenytoin. The isolated biopolymer was characterized for DSC, FTIR, NMR, mass, and scanning electron microscopy. The isolated biomaterial was used for the preparation of phenytoin-loaded bionanosuspension with other excipients. The bionanoparticles were also characterized by different analytical testing such as FTIR, DSC, and SEM to confirm any interaction between model drug and biopolymer. The prepared bionanoparticles showed the release of phenytoin in a sustained manner over 36 hours. The release kinetic study was done using the BIT-SOFT 1.12 software and other parameters such as t50%, t80%, and were calculated. The formulation PFr6 was considered best having t50% in 18.22 hours and t80% in 29.62 h with an r value of 0.9793. This formulation showed up to 87.89% drug release within 36 hours. The prepared bio-nanosuspension was found to be stable and in a well-dispersed state. The dried bionanosuspension evaluation revealed no interaction between model drug and biopolymer without any loss of characteristic peaks. Therefore, the isolated biopolymer can be safely used to prepare stable bionanosuspension loaded with nanosized phenytoin.

摘要

该研究旨在利用从水果中分离出的具有潜在天然聚合物特性的生物聚合物开发生物纳米混悬液。首先,通过一种经济的分离方法从天然果肉中分离出生物材料。采用新型超声处理方法将模型药物纳米化。对分离出的生物聚合物的聚合特性进行了表征,并评估了其在纳米尺寸苯妥英钠递送中的潜在能力。对分离出的生物聚合物进行了差示扫描量热法(DSC)、傅里叶变换红外光谱法(FTIR)、核磁共振(NMR)、质谱和扫描电子显微镜表征。将分离出的生物材料与其他辅料用于制备载苯妥英钠的生物纳米混悬液。还通过FTIR、DSC和SEM等不同分析测试对生物纳米颗粒进行了表征,以确认模型药物与生物聚合物之间的任何相互作用。制备的生物纳米颗粒在36小时内显示出苯妥英钠的持续释放。使用BIT - SOFT 1.12软件进行释放动力学研究,并计算t50%、t80%等其他参数。制剂PFr6被认为是最佳制剂,其t50%为18.22小时,t80%为29.62小时,r值为0.9793。该制剂在36小时内显示出高达87.89%的药物释放。发现制备的生物纳米混悬液稳定且处于良好分散状态。干燥的生物纳米混悬液评估显示模型药物与生物聚合物之间没有相互作用,且特征峰没有任何损失。因此,分离出的生物聚合物可安全用于制备载纳米尺寸苯妥英钠的稳定生物纳米混悬液。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03f9/8653676/56a666cfcb6a/ijpr-20-78-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03f9/8653676/4b860c21a67e/ijpr-20-78-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03f9/8653676/c9e885aac8f8/ijpr-20-78-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03f9/8653676/0bda22bcdc77/ijpr-20-78-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03f9/8653676/bef68f878824/ijpr-20-78-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03f9/8653676/8764e0e502e7/ijpr-20-78-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03f9/8653676/5bd17429ac80/ijpr-20-78-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03f9/8653676/b88596e89794/ijpr-20-78-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03f9/8653676/e27e3c181f77/ijpr-20-78-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03f9/8653676/56a666cfcb6a/ijpr-20-78-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03f9/8653676/4b860c21a67e/ijpr-20-78-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03f9/8653676/c9e885aac8f8/ijpr-20-78-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03f9/8653676/0bda22bcdc77/ijpr-20-78-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03f9/8653676/bef68f878824/ijpr-20-78-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03f9/8653676/8764e0e502e7/ijpr-20-78-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03f9/8653676/5bd17429ac80/ijpr-20-78-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03f9/8653676/b88596e89794/ijpr-20-78-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03f9/8653676/e27e3c181f77/ijpr-20-78-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03f9/8653676/56a666cfcb6a/ijpr-20-78-g009.jpg

相似文献

1
Exploration of Inbuilt Novel Properties as Bioretardant Cum Stabilizer of Isolated Biopolymer from in Delivery of Nanosized Phenytoin.探索作为纳米级苯妥英递送中分离出的生物聚合物的生物阻滞剂兼稳定剂的内在新特性。
Iran J Pharm Res. 2021 Summer;20(3):78-93. doi: 10.22037/ijpr.2021.113734.14457.
2
Biopolymeric nanoencapsulation of model drug: Its development and characterisation.生物聚合物纳米胶囊化模型药物:其制备与表征。
Pak J Pharm Sci. 2024 Jan;37(1):85-94.
3
Inbuilt novel bioretardant feature of biopolymer isolated from for designing drug loaded bionanosuspension.从……分离出的生物聚合物的内在新型生物阻滞剂特性,用于设计载药生物纳米混悬液。 (原文中“from”后缺少具体内容)
J Drug Assess. 2020 Mar 31;9(1):72-81. doi: 10.1080/21556660.2020.1745210. eCollection 2020.
4
Design of selegiline-loaded bio-nanosuspension for the management of depression using novel bio-retardant from .载有司来吉兰的生物纳米混悬剂的设计,用于利用 新型生物阻滞剂治疗抑郁症。
Drug Dev Ind Pharm. 2019 Aug;45(8):1351-1360. doi: 10.1080/03639045.2019.1619760. Epub 2019 May 28.
5
A quality-by-design study to develop Nifedipine nanosuspension: examining the relative impact of formulation variables, wet media milling process parameters and excipient variability on drug product quality attributes.基于质量源于设计的硝苯地平纳米混悬剂的研制:考察制剂变量、湿磨工艺参数和辅料变异性对药物产品质量属性的相对影响。
Drug Dev Ind Pharm. 2018 Dec;44(12):1942-1952. doi: 10.1080/03639045.2018.1503296. Epub 2018 Oct 12.
6
Clarifying the identity of the main ellagitannin in the fruit of the strawberry, Fragaria vesca and Fragaria ananassa Duch.澄清草莓(Fragaria vesca 和 Fragaria ananassa Duch.)果实中主要鞣花单宁的身份。
J Agric Food Chem. 2012 Mar 14;60(10):2507-16. doi: 10.1021/jf2052256. Epub 2012 Mar 1.
7
Investigation of nanosized crystalline form to improve the oral bioavailability of poorly water soluble cilostazol.研究纳米晶型以提高难溶性西洛他唑的口服生物利用度。
J Pharm Pharm Sci. 2011;14(2):196-214. doi: 10.18433/j3pw2w.
8
Influence of the preparation procedure and chitosan type on physicochemical properties and release behavior of alginate-chitosan microparticles.海藻酸钠-壳聚糖微球的制备工艺和壳聚糖类型对其理化性质和释放行为的影响。
Drug Dev Ind Pharm. 2009 Sep;35(9):1092-102. doi: 10.1080/03639040902774164.
9
[Studies on chemical constituents of Fragaria ananassa Duch].[凤梨草莓化学成分的研究]
Zhongguo Zhong Yao Za Zhi. 2001 Sep;26(9):610-2.
10
Formulation of spray-dried phenytoin loaded poly(epsilon-caprolactone) microcarrier intended for brain delivery to treat epilepsy.用于脑部给药治疗癫痫的喷雾干燥载苯妥英聚(ε-己内酯)微载体的制剂
J Pharm Sci. 2007 May;96(5):1018-30. doi: 10.1002/jps.20935.

本文引用的文献

1
Inbuilt novel bioretardant feature of biopolymer isolated from for designing drug loaded bionanosuspension.从……分离出的生物聚合物的内在新型生物阻滞剂特性,用于设计载药生物纳米混悬液。 (原文中“from”后缺少具体内容)
J Drug Assess. 2020 Mar 31;9(1):72-81. doi: 10.1080/21556660.2020.1745210. eCollection 2020.
2
Development of novel active packaging films based on whey protein isolate incorporated with chitosan nanofiber and nano-formulated cinnamon oil.基于乳清蛋白分离物与壳聚糖纳米纤维和纳米配方肉桂油的新型活性包装膜的开发。
Int J Biol Macromol. 2020 Apr 15;149:11-20. doi: 10.1016/j.ijbiomac.2020.01.083. Epub 2020 Jan 30.
3
Design of selegiline-loaded bio-nanosuspension for the management of depression using novel bio-retardant from .
载有司来吉兰的生物纳米混悬剂的设计,用于利用 新型生物阻滞剂治疗抑郁症。
Drug Dev Ind Pharm. 2019 Aug;45(8):1351-1360. doi: 10.1080/03639045.2019.1619760. Epub 2019 May 28.
4
Topical phenytoin nanostructured lipid carriers: design and development.局部用苯妥英纳米结构脂质载体:设计与开发
Drug Dev Ind Pharm. 2018 Jan;44(1):144-157. doi: 10.1080/03639045.2017.1386204. Epub 2017 Oct 17.
5
Recent advances in epilepsy.癫痫的最新进展
J Neurol. 2017 Aug;264(8):1811-1824. doi: 10.1007/s00415-017-8394-2. Epub 2017 Jan 24.
6
Electroresponsive Nanoparticles Improve Antiseizure Effect of Phenytoin in Generalized Tonic-Clonic Seizures.电响应性纳米颗粒增强苯妥英对全身强直阵挛性癫痫发作的抗癫痫作用。
Neurotherapeutics. 2016 Jul;13(3):603-13. doi: 10.1007/s13311-016-0431-9.
7
Rational Design and Characterization of a Nanosuspension for Intraoral Administration Considering Physiological Conditions.考虑生理条件的口腔给药纳米混悬液的合理设计与表征
J Pharm Sci. 2016 Jan;105(1):257-67. doi: 10.1016/j.xphs.2015.10.021. Epub 2015 Dec 19.
8
Natural Polymeric Nanoparticles for Brain-Targeting: Implications on Drug and Gene Delivery.用于脑靶向的天然聚合物纳米颗粒:对药物和基因递送的影响
Curr Pharm Des. 2016;22(22):3305-23. doi: 10.2174/1381612822666160204120829.
9
Modulation of mononuclear phagocyte inflammatory response by liposome-encapsulated voltage gated sodium channel inhibitor ameliorates myocardial ischemia/reperfusion injury in rats.脂质体包裹的电压门控钠离子通道抑制剂调节单核吞噬细胞炎症反应减轻大鼠心肌缺血/再灌注损伤。
PLoS One. 2013 Sep 19;8(9):e74390. doi: 10.1371/journal.pone.0074390. eCollection 2013.
10
Tolerability, safety, and side effects of levetiracetam versus phenytoin in intravenous and total prophylactic regimen among craniotomy patients: a prospective randomized study.左乙拉西坦与苯妥英钠在开颅术患者静脉和全预防方案中的耐受性、安全性和副作用:一项前瞻性随机研究。
Epilepsia. 2013 Jan;54(1):45-57. doi: 10.1111/j.1528-1167.2012.03563.x. Epub 2012 Jun 27.